Page last updated: 2024-11-05

tetraethyltin

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Cross-References

ID SourceID
PubMed CID11704
MeSH IDM0102031

Synonyms (27)

Synonym
nsc22315
tetraethyltin
tetraethylstannane
stannane, tetraethyl-
597-64-8
wln: 2-sn-2&2&2
nsc-22315
tin, tetraethyl-
tetraethyl tin
brn 3600335
hsdb 6398
nsc 22315
einecs 209-906-2
inchi=1/4c2h5.sn/c4*1-2;/h4*1h2,2h3;
rwwnqeopuockgr-uhfffaoysa-
tetraethyltin, 97%
31re6na75o ,
unii-31re6na75o
tetraethyl tin [hsdb]
et4sn
snet4
(c2h5)4sn
DTXSID9022073
mfcd00009020
tetraethylstannane; nsc 22315; tetraethyltin
tin tetraethyl
Q186600

Research Excerpts

Dosage Studied

ExcerptRelevanceReference
" The battery of tests was administered on eight occasions, that is, before, at three-week intervals during dosing (PO or IP, five days each week for 15 weeks), and at three and six weeks after dosing."( Assessment of chemicals using a battery of neurobehavioral tests: a comparative study.
Mitchell, CL; Pryor, GT; Tilson, HA; Uyeno, ET,
)
0.13
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (8)

TimeframeStudies, This Drug (%)All Drugs %
pre-19905 (62.50)18.7374
1990's1 (12.50)18.2507
2000's2 (25.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 25.05

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be moderate demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index25.05 (24.57)
Research Supply Index2.40 (2.92)
Research Growth Index4.11 (4.65)
Search Engine Demand Index26.67 (26.88)
Search Engine Supply Index2.00 (0.95)

This Compound (25.05)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews0 (0.00%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other10 (100.00%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]